BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33500829
Number of visits today
5389
Number of downloads
16686397
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Debom GN, Rubenich DS, Braganhol E. Adenosinergic Signaling as a Key Modulator of the Glioma Microenvironment and Reactive Astrocytes. Front Neurosci 2021;15:648476. [PMID: 35069091 DOI: 10.3389/fnins.2021.648476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Gelsleichter NE, Azambuja JH, Rubenich DS, Braganhol E. CD73 in glioblastoma: Where are we now and what are the future directions? Immunol Lett 2023:S0165-2478(23)00040-8. [PMID: 36958430 DOI: 10.1016/j.imlet.2023.03.005] [Reference Citation Analysis]
2 Barnes DA, Hoener MC, Moore CS, Berry MD. TAAR1 Regulates Purinergic-induced TNF Secretion from Peripheral, But Not CNS-resident, Macrophages. J Neuroimmune Pharmacol 2022. [DOI: 10.1007/s11481-022-10053-8] [Reference Citation Analysis]
3 Huang Q, Chen L, Liang J, Huang Q, Sun H. Neurotransmitters: Potential Targets in Glioblastoma. Cancers 2022;14:3970. [DOI: 10.3390/cancers14163970] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ferrari D, Gessi S, Merighi S, Nigro M, Travagli A, Burns JS. Potentiating Cancer Immune Therapy via Nanomaterials and Purinergic Signaling. Front Cell Dev Biol 2022;10:893709. [DOI: 10.3389/fcell.2022.893709] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345